LRI Investments LLC Cuts Stock Holdings in Kenvue Inc. $KVUE

LRI Investments LLC reduced its stake in shares of Kenvue Inc. (NYSE:KVUE) by 26.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 12,648 shares of the company’s stock after selling 4,445 shares during the quarter. LRI Investments LLC’s holdings in Kenvue were worth $265,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in KVUE. Vanguard Group Inc. grew its position in Kenvue by 4.9% during the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock worth $5,494,882,000 after buying an additional 10,600,682 shares during the period. Third Point LLC purchased a new position in shares of Kenvue during the first quarter valued at approximately $213,422,000. Maverick Capital Ltd. purchased a new position in shares of Kenvue during the first quarter valued at approximately $203,036,000. Nuveen LLC purchased a new position in shares of Kenvue during the first quarter valued at approximately $187,123,000. Finally, Voya Investment Management LLC lifted its stake in shares of Kenvue by 131.3% during the first quarter. Voya Investment Management LLC now owns 12,131,468 shares of the company’s stock valued at $290,557,000 after buying an additional 6,886,784 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on KVUE shares. Canaccord Genuity Group reduced their price objective on shares of Kenvue from $29.00 to $26.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. Barclays cut their price target on shares of Kenvue from $20.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Rothschild Redb raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 26th. Redburn Partners set a $22.00 price target on shares of Kenvue in a research note on Friday, September 26th. Finally, JPMorgan Chase & Co. cut their price target on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $21.18.

Kenvue Stock Performance

Shares of KVUE stock opened at $16.68 on Monday. The company’s fifty day simple moving average is $19.15 and its 200-day simple moving average is $21.31. Kenvue Inc. has a 52 week low of $15.47 and a 52 week high of $25.17. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The company has a market cap of $32.00 billion, a PE ratio of 22.53, a P/E/G ratio of 2.39 and a beta of 0.72.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. The business had revenue of $3.84 billion during the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The business’s revenue was down 4.0% on a year-over-year basis. During the same period last year, the business earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date of this dividend was Wednesday, August 13th. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s dividend payout ratio (DPR) is 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.